Swixx Biopharma Is A Global Commercial Platform That Provides End To End Commercialization Services For Biopharmaceuticalotcand Medical Device Companiesthe Company Operates Fully Owned Subsidiaries In Central And Eastern Europerussia Eurasiagreecethe Middle Eastand Latin Americaemploying Over 1 300 Peoplewith Projected Sales Exceeding A 1 Billion In 2024Swixx Has Established Itself As A Leading Independent Partner In Multiple Regions Swixx Offers A Range Of Servicesincluding Market Entry And Exit Solutionsdistribution Of Rare Diseases And Specialty Drugsand Regulatorymarketingand Sales Support Tailored To Local Healthcare Ecosystemsthe Company Commercializes Products For Partnersfocusing On Rx Pharmaceuticalsotc Productsand Medical Devicesswixx Collaborates With Innovative Biopharma Companies Like Albireoamgenand Bristol Myers Squibbtargeting Multinationals Seeking Indirect Market Access In Complex Regulatory Environmentsits Mission Is To Enhance Global Patient Access To Innovative Treatmentsparticularly In Rare Diseases And Oncology
